Esen K. Akpek
Johns Hopkins University School of Medicine
196 Papers
989 Citations
Esen K. Akpek is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Medicine & Keratoprosthesis. The author has an hindex of 42, co-authored 166 publications. Previous affiliations of Esen K. Akpek include Johns Hopkins University & Harvard University.
Chat about Author
Papers
Prevalence of novel Sjögren's antibodies in a multi-center cohort of dry eye patients.
David Hsu,Yinxi Yu,Esen K. Akpek,Lee Guo,Tiffany Liu,Mina Massaro-Giordano,Soo Abboud,Franz Fogt,Devica L. Bhutani,Emma Iacobucci,Jay Pendyala,F. Vivino,Alan N. Baer,Gui-Shuang Ying,Vatinee Y Bunya +14 more
Outcomes of Repeat Boston Type 1 Keratoprosthesis Implantation
Sumayya Ahmad,Priya M. Mathews,Divya Srikumaran,Anthony J. Aldave,Tamara L. Lenis,James V. Aquavella,Sadeer B. Hannush,Michael W. Belin,Esen K. Akpek +8 more
TL;DR: In this paper, the authors describe the outcomes and prognostic characteristics of patients who had a repeat Boston type 1 keratoprosthesis (KPro) implantation, which resulted in restoration of vision.
Conjunctival lymphoma masquerading as chronic conjunctivitis
TL;DR: The authors describe the clinical and histopathologic findings of two patients with bilateral conjunctival lymphoma who presented with a history of chronic conjunctivitis without clinically noticeable subconjunctival nodules who subsequently received radiation therapy and achieved a complete remission.
Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye.
TL;DR: This cross-sectional study demonstrated that anti-CA6 is seen in patients with severe aqueous-deficient dry eye, and whether these patients have an early stage of SS or a different type of autoimmune condition may be determined through longitudinal studies.
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities.
Claes H. Dohlman,Fabiano Cade,Caio V. Regatieri,Chengxin Zhou,Fengyang Lei,Alja Crnej,Mona Harissi-Dagher,Marie-Claude Robert,George N. Papaliodis,Dongfeng Chen,James V. Aquavella,Esen K. Akpek,Anthony J. Aldave,Kimberly C. Sippel,Donald J DʼAmico,Jan G. Dohlman,P. Fagerholm,Liqiang Wang,Lucy Q. Shen,Miguel Gonzalez-Andrades,James Chodosh,Kenneth R. Kenyon,C. Stephen Foster,Roberto Pineda,Samir A. Melki,Kathryn Colby,Joseph B. Ciolino,Demetrios G. Vavvas,Shigeru Kinoshita,Reza Dana,Eleftherios I. Paschalis +30 more
TL;DR: A new regimen, in addition to standard treatment, for severe chemical burns is proposed, which involves tumor necrosis factor alpha inhibition promptly after the accident, prophylactic maximal lowering of the intraocular pressure, and keratoprosthesis implantation in a later quiet state.